These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7923175)

  • 41. Signaling defects in anti-tumor T cells.
    Frey AB; Monu N
    Immunol Rev; 2008 Apr; 222():192-205. PubMed ID: 18364003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.
    Rodríguez PC; Ochoa AC
    Immunol Rev; 2008 Apr; 222():180-91. PubMed ID: 18364002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes.
    Diegmann J; Junker K; Loncarevic IF; Michel S; Schimmel B; von Eggeling F
    Neoplasia; 2006 Nov; 8(11):933-8. PubMed ID: 17132225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allogeneic stem-cell transplantation in renal-cell carcinoma.
    Hayes-Lattin BM; Maziarz RT; Beer TM
    Curr Oncol Rep; 2001 Sep; 3(5):433-7. PubMed ID: 11489245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinase inhibitors in cancer therapy: a look ahead.
    Sedlacek HH
    Drugs; 2000 Mar; 59(3):435-76. PubMed ID: 10776829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.
    Uzzo RG; Rayman P; Kolenko V; Clark PE; Cathcart MK; Bloom T; Novick AC; Bukowski RM; Hamilton T; Finke JH
    J Clin Invest; 1999 Sep; 104(6):769-76. PubMed ID: 10491412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.
    Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP
    J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.
    Kiessling R; Kono K; Petersson M; Wasserman K
    Springer Semin Immunopathol; 1996; 18(2):227-42. PubMed ID: 8908702
    [No Abstract]   [Full Text] [Related]  

  • 50. IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells.
    Zier KS; Gansbacher B
    J Mol Med (Berl); 1996 Mar; 74(3):127-34. PubMed ID: 8846162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes.
    Bryan RG; Li Y; Totten RK; Van M; Tan TH; Rich RR
    Cell Immunol; 1994 Aug; 157(1):158-69. PubMed ID: 8039243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression.
    Ng CS; Novick AC; Tannenbaum CS; Bukowski RM; Finke JH
    Urology; 2002 Jan; 59(1):9-14. PubMed ID: 11796271
    [No Abstract]   [Full Text] [Related]  

  • 53. T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.
    Li X; Liu J; Park JK; Hamilton TA; Rayman P; Klein E; Edinger M; Tubbs R; Bukowski R; Finke J
    Cancer Res; 1994 Oct; 54(20):5424-9. PubMed ID: 7923175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
    Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
    Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy.
    Ghosh P; Sica A; Young HA; Ye J; Franco JL; Wiltrout RH; Longo DL; Rice NR; Komschlies KL
    Cancer Res; 1994 Jun; 54(11):2969-72. PubMed ID: 8187083
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.